Johnson & Johnson
OpenCalais Metadata: Ticker: 
JNJ
  • An experimental drug that failed to stop mental decline in Alzheimer's patients also showed some potential benefit, fuller results of two major studies now show.

    LAST UPDATE : Dec 06, 2012, 10:00 PM EST
    Story

Pages